Helenalin and 11 alpha,13-dihydrohelenalin, two constituents from Arnica montana L., inhibit human platelet function via thiol-dependent pathways

Thromb Res. 1990 Mar 15;57(6):839-45. doi: 10.1016/0049-3848(90)90151-2.

Abstract

This study investigates the effect on human platelet function of two sesquiterpene lactones from Arnica montana L., helenalin (H) and 11 alpha,13-dihydrohelenalin (DH). Both compounds inhibited collagen-induced platelet aggregation, thromboxane formation and 5-hydroxytryptamine secretion in a concentration-dependent manner at 3-300 microM. When arachidonic acid was used as stimulus, thromboxane formation remained unaffected despite of inhibition of platelet aggregation. Both H and DH reduced the number of acid-soluble sulfhydryl groups in platelets, by up to 78% at anti-aggregatory concentrations. Moreover, H- and DH-induced platelet inhibition could be prevented by the thiol containing amino acid cysteine. It is concluded that H and DH inhibit platelet function via interaction with platelet sulfhydryl groups, probably associated with reduced phospholipase A2 activity.

Publication types

  • Comparative Study

MeSH terms

  • Arachidonic Acid
  • Arachidonic Acids / pharmacology
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Cysteine / pharmacology
  • Humans
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A2
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / pharmacology*
  • Serotonin / metabolism
  • Sesquiterpenes / pharmacology*
  • Sesquiterpenes, Guaiane
  • Sulfhydryl Reagents / pharmacology
  • Thromboxane B2 / biosynthesis

Substances

  • Arachidonic Acids
  • Platelet Aggregation Inhibitors
  • Sesquiterpenes
  • Sesquiterpenes, Guaiane
  • Sulfhydryl Reagents
  • Arachidonic Acid
  • Serotonin
  • helenalin
  • Thromboxane B2
  • Phospholipases A
  • Phospholipases A2
  • Cysteine